Home owners will see housing assistance in the upcoming fiscal year with an income-based ResidentFirst pilot program the city ...

Apply for wage top-up, professional development, release time and mandatory employer contribution funding for certified staff.

Mercury’s radiation-tolerant SSDRs are leveraged on all four tranches that L3Harris is developing for the PWSA Tracking Layer ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Through a series of smaller efforts such as solidifying disaster recovery programs, funding low-income home repairs and ...

NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Encouraging Phase 2 HIT data and recent FDA feedback support continued advancement of CAD-1005 as Cadrenal’s near-term development priority; broader 12-LOX platform remains a longer-term opportunity ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

NPR Global Health and Development Correspondent Fatma Tanis talks about digging into the impact of billions of dollars of US aid being cut from programs around the world.

Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the ...

(Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced ...

The Trump administration dropped its fiscal 2027 budget request Friday, and the massive document release includes some ...